The Effect of Status on Radio-Sensitivity of Quiescent Tumor Cell Population Irradiated With γ-Rays at Various Dose Rates
Overview
Affiliations
Background: The aim of the study was to clarify the effect of status of tumor cells on radio-sensitivity of solid tumors following γ-ray irradiation at various dose rates, referring to the response of intratumor quiescent (Q) cells.
Methods: Human head and neck squamous cell carcinoma cells transfected with mutant (SAS/) or with neo vector (SAS/) were injected subcutaneously into hind legs of nude mice. Tumor bearing mice received 5-bromo-2'-deoxyuridine (BrdU) continuously to label all intratumor proliferating (P) cells. They received γ-rays at a high, middle or low dose rate. Immediately or 9 h after the high dose-rate irradiation (HDR, 2.5 Gy/min), or immediately after the middle (MDR, 0.039 Gy/min) or low (LDR, 0.00098 Gy/min) dose-rate irradiation, the tumor cells were isolated and incubated with a cytokinesis blocker, and the micronucleus (MN) frequency in cells without BrdU labeling (Q cells) was determined using immunofluorescence staining for BrdU.
Results: Following γ-ray irradiation, SAS/ tumor cells, especially intratumor Q cells, showed a marked reduction in sensitivity due to the recovery from radiation-induced damage, compared with the total or Q cells within SAS/ tumors that showed little repair capacity. The recovery capacities following γ-ray irradiation were greater in Q than total cell population and increased in the following order of 9 h after HDR < MDR < LDR. Thus, the difference in radio-sensitivity between the total (P + Q) and Q cells after γ-ray irradiation increased in the same order.
Conclusion: To secure controlling solid tumors as a whole, difference in sensitivity between total and Q tumor cells especially in solid tumors irrespective of status has to be suppressed as irradiation dose rate decreases, for instance, through employing combined method for enhancing the response of Q tumor cells.
Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members.
Kaida A, Iwakuma T Int J Mol Sci. 2021; 22(24).
PMID: 34948322 PMC: 8706882. DOI: 10.3390/ijms222413527.
Boron neutron capture therapy: Current status and future perspectives.
Dymova M, Taskaev S, Richter V, Kuligina E Cancer Commun (Lond). 2020; 40(9):406-421.
PMID: 32805063 PMC: 7494062. DOI: 10.1002/cac2.12089.
Masunaga S, Sanada Y, Tano K, Sakurai Y, Tanaka H, Takata T J Radiat Res. 2020; 61(6):876-885.
PMID: 32601693 PMC: 7674684. DOI: 10.1093/jrr/rraa048.